FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022]

Side Effects & Adverse Event Reports


View Chart Data

6.5K

Adverse Events

26.7K

Side Effects

2009

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022].

Understanding the potential Side Effects and Adverse Events of FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022]?

    FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] has 6,548 adverse event reports in this SymPedia dataset.

  • How many side effects have been reported for FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022]?

    FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] has 26,710 side effect reports in this SymPedia dataset.

  • What year does the FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022] reporting data start?

    The reporting data on this page starts in 2009.

  • What years are included in the yearly chart for FAMOTIDINE 20 MG ORAL TABLET [ZANTAC REFORMULATED AUG 2022]?

    The yearly chart on this page includes data from 2009 to 2025.